C24.8 - Malignant neoplasm of overlapping sites of biliary tract

Version 2023
ICD-10:C24.8
Short Description:Malignant neoplasm of overlapping sites of biliary tract
Long Description:Malignant neoplasm of overlapping sites of biliary tract
Status: Valid for Submission
Version:ICD-10-CM 2023
Code Classification:
  • Neoplasms (C00–D48)
    • Malignant neoplasms of digestive organs (C15-C26)
      • Malignant neoplasm of other and unsp parts of biliary tract (C24)

C24.8 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of overlapping sites of biliary tract. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.

The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic bile or biliary (tract) duct or passage (common) (cystic) (extrahepatic) intrahepatic and extrahepatic or Neoplasm, neoplastic extrahepatic (bile) duct overlapping lesion with gallbladder or Neoplasm, neoplastic gallbladder overlapping lesion with extrahepatic bile ducts .

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to this diagnosis code:


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

Convert to ICD-9 Code

Source ICD-10 CodeTarget ICD-9 Code
C24.8156.8 - Malig neo biliary NEC

Table of Neoplasms

This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »bile or biliary (tract)
    »duct or passage (common) (cystic) (extrahepatic)
      »intrahepatic
        »and extrahepatic
C24.8C78.89D01.5D13.5D37.6D49.0
»Neoplasm, neoplastic
  »extrahepatic (bile) duct
    »overlapping lesion with gallbladder
C24.8
»Neoplasm, neoplastic
  »gallbladder
    »overlapping lesion with extrahepatic bile ducts
C24.8

Patient Education


Bile Duct Cancer

Your liver makes a digestive juice called bile. Your gallbladder stores it between meals. When you eat, your gallbladder pushes the bile into tubes called bile ducts. They carry the bile to your small intestine. The bile helps break down fat. It also helps the liver get rid of toxins and wastes.

Bile duct cancer is rare. It can happen in the parts of the bile ducts that are outside or inside the liver. Cancer of the bile duct outside of the liver is much more common. Risk factors include having inflammation of the bile duct, ulcerative colitis, and some liver diseases.

Symptoms can include:

Tests to diagnose bile duct cancer may include a physical exam, imaging tests of the liver and bile ducts, blood tests, and a biopsy.

Treatments include surgery, radiation therapy, and chemotherapy.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

What is Bile Duct Cancer (Cholangiocarcinoma)?

Learn about bile duct cancer (cholangiocarcinoma) risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History